Literature DB >> 15177086

Pathophysiology of depression: the concept of synaptic plasticity.

R S Duman1.   

Abstract

Neuronal plasticity or remodeling is most often discussed with regard to cellular and behavioral models of learning and memory. However, neuronal plasticity is a fundamental process by which the brain acquires information and makes the appropriate adaptive responses in future-related settings. Dysfunction of these fundamental processes could thereby contribute to the pathophysiology of mood disorders, and recovery could occur by induction of the appropriate plasticity or remodeling. These possibilities are supported by preclinical and clinical studies demonstrating that there are structural alterations that occur in response to stress and in patients with mood disorders. Moreover, antidepressant treatment may oppose these effects by regulation of signal transduction and gene expression pathways linked to neuronal plasticity. These findings comprise a novel conceptual framework for future studies of the etiology of mood disorders and for the development of novel therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15177086     DOI: 10.1016/s0924-9338(02)00654-5

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  100 in total

Review 1.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

2.  BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.

Authors:  George S Alexopoulos; Charles E Glatt; Matthew J Hoptman; Dora Kanellopoulos; Christopher F Murphy; Robert E Kelly; Sarah S Morimoto; Kelvin O Lim; Faith M Gunning
Journal:  J Affect Disord       Date:  2010-03-25       Impact factor: 4.839

3.  Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus.

Authors:  Maryam Ardalan; Ali H Rafati; Jens R Nyengaard; Gregers Wegener
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

4.  Effects of early-life adversity on white matter diffusivity changes in patients at risk for major depression.

Authors:  Thomas Frodl; Angela Carballedo; Andrew J Fagan; Danuta Lisiecka; Yolande Ferguson; James F Meaney
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

Review 5.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

6.  Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response.

Authors:  Mmalebuso L Mokoena; Brian H Harvey; Francois Viljoen; Susanna M Ellis; Christiaan B Brink
Journal:  Psychopharmacology (Berl)       Date:  2015-04-17       Impact factor: 4.530

7.  Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain.

Authors:  Emilio L Streck; Gislaine T Rezin; Luciana M Barbosa; Lara C Assis; Eliane Grandi; João Quevedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-03       Impact factor: 3.000

Review 8.  Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Authors:  Richard S Jope; Myoung-Sun Roh
Journal:  Curr Drug Targets       Date:  2006-11       Impact factor: 3.465

9.  Stress exacerbates experimental Parkinson's disease.

Authors:  A M Hemmerle; J W Dickerson; J P Herman; K B Seroogy
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

10.  Genetics of PTSD: Fear Conditioning as a Model for Future Research.

Authors:  Ananda B Amstadter; Nicole R Nugent; Karestan C Koenen
Journal:  Psychiatr Ann       Date:  2009-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.